Medical Properties Trust INC

Medical Properties Trust, Inc. shareholders re-elected nine directors and approved the company's executive compensation and equity incentive plan at the 2026 annual meeting.

Medical Properties Trust, Inc. announced its financial and operating results for the first quarter ended March 31, 2026, reporting net income of $0.05 per share and Normalized Funds from Operations (NFFO) of $0.14 per share.

Medical Properties Trust announced its fourth quarter and full-year 2025 financial results, highlighting portfolio transitions, new leases, and balance sheet strengthening efforts.

Medical Properties Trust announced a brand refresh, including a NYSE ticker symbol change from MPW to MPT and a headquarters relocation, effective February 2, 2026.

Medical Properties Trust reported a net loss of $0.13 per share for Q3 2025 but announced a $150 million stock repurchase program and expects cash rents to exceed $1 billion by end of 2026.

Medical Properties Trust, Inc. entered into an equity distribution agreement to offer and sell up to $500 million of its common stock, including potential forward sale transactions.

Medical Properties Trust reports Q1 2026 net income of $32.8 million, driven by revenue growth and a one-time U.K. tax benefit.

Medical Properties Trust reports significantly reduced net losses in Q3 2025, driven by lower impairment charges, despite a decline in Normalized FFO and ongoing challenges with tenant bankruptcies.

Medical Properties Trust reported a significantly reduced net loss for the second quarter of 2025 compared to the prior year, primarily due to lower impairment charges, despite a notable decrease in total revenues and Normalized FFO.

Medical Properties Trust faces net losses in Q1 2025 due to tenant bankruptcies and fair value adjustments, while strategically refinancing debt to improve financial flexibility.

Medical Properties Trust and MPT Operating Partnership filed an amended quarterly report to include an exhibit that was inadvertently omitted from the original filing.

Medical Properties Trust reported a substantial net loss of $801.2 million for the third quarter of 2024, primarily due to impairment charges and fair value adjustments.

Medical Properties Trust reports a significantly reduced net loss in 2025, driven by debt refinancing and strategic re-tenanting efforts, despite ongoing tenant bankruptcies.

Medical Properties Trust (MPT) reports a challenging year marked by tenant bankruptcies and strategic shifts towards liquidity enhancement and debt management.

Medical Properties Trust reports a significant net loss of $556 million for 2023, primarily due to tenant-related issues and impairment charges, despite strategic asset sales and cost-cutting measures.

Charles R. Lambert, SVP of Finance and Treasurer at Medical Properties Trust Inc. (MPT), reported a transaction involving the withholding of shares to cover tax obligations.

Larry H. Portal, SVP Senior Advisor to the CEO at Medical Properties Trust Inc., reported a transaction involving 4,048 shares of common stock on July 8, 2026, to cover tax withholding obligations.

Edward K. Aldag Jr., Chairman, President & CEO of Medical Properties Trust Inc. (MPT), reported a transaction involving common stock.

R. Steven Hamner, Executive Vice President & CFO of Medical Properties Trust Inc. (MPT), reported a transaction involving the withholding of shares to cover tax obligations.

James Kevin Hanna, Senior VP, Controller & CAO of Medical Properties Trust Inc., acquired 3,295 shares of common stock and withheld shares to cover tax obligations.

Rosa Handley, SVP of Operations at Medical Properties Trust Inc., reported a transaction involving common stock.

Medical Properties Trust announces its 2026 Annual Meeting of Stockholders, scheduled for May 28, 2026, in Birmingham, Alabama, with proxy materials and the annual report being made available on or about April 13, 2026.

Medical Properties Trust (MPT) issues supplemental proxy materials to address concerns raised by Institutional Shareholder Services (ISS) regarding executive compensation, emphasizing alignment with shareholder interests and company performance.

Medical Properties Trust's 2025 proxy statement details executive compensation adjustments, strategic plan execution, and proactive stockholder engagement amidst challenging market conditions.

Medical Properties Trust, Inc. is holding its annual shareholder meeting on May 29, 2025, and has released proxy materials for voting on director elections, auditor ratification, and executive compensation.

Medical Properties Trust (MPT) is urging stockholders to approve its executive compensation program, emphasizing its alignment with company performance and proactive changes made in response to shareholder feedback.

Medical Properties Trust, Inc. will hold its annual shareholder meeting on May 30, 2024, to vote on the election of directors, ratification of the company's accounting firm, and executive compensation.

Vanguard Portfolio Management has reported a beneficial ownership of 7.21% in Medical Properties Trust Inc. common stock as of March 31, 2026.

The Vanguard Group has reported zero beneficial ownership in Medical Properties Trust Inc. following an internal realignment and disaggregated reporting strategy.

He Zhengxu has reported an increased beneficial ownership of 6.9% in Medical Properties Trust Inc., holding over 41 million shares.

State Street Corporation has reported a 4.5% beneficial ownership stake in Medical Properties Trust Inc. common stock as of September 30, 2025.

BlackRock, Inc. has reported an 11.5% beneficial ownership stake in Medical Properties Trust Inc., holding over 69 million shares of common stock.

The Vanguard Group has reported a beneficial ownership of 11.76% in Medical Properties Trust Inc., holding over 70 million shares of common stock.